Improving the reporting of clinical trials of infertility treatments (IMPRINT): modifying the CONSORT statement†‡.

ABSTRACT: Clinical trials testing infertility treatments often do not report on the major outcomes of interest to patients and clinicians and the public (such as live birth) nor on the harms, including maternal risks during pregnancy and fetal anomalies. This is complicated by the multiple participants in infertility trials which may include a woman (mother), a man (father), and result in a third individual if successful, their offspring (child), who is also the desired outcome of treatment. The primary outcome of interest and many adverse events occur after cessation of infertility treatment and during pregnancy and the puerperium, which create a unique burden of follow-up for clinical trial investigators and participants. In 2013, because of the inconsistencies in trial reporting and the unique as

SUBMITTER: Harbin Consensus Conference Workshop Group 

PROVIDER: S-EPMC4481576 | biostudies-literature | 2014 Oct

REPOSITORIES: biostudies-literature